✦ LIBER ✦

Cetuximab/irinotecan response influenced by SNPs in colorectal cancer

Book ID: 120844476
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 151 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816340-00028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cetuximab Monotherapy and Cetuximab plus

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

✍ Cunningham, David; Humblet, Yves; Siena, Salvatore; Khayat, David; Bleiberg, Har 📂 Article 📅 2004 🏛 Massachusetts Medical Society 🌐 English ⚖ 129 KB

Bevacizumab + cetuximab ± irinotecan imp

Bevacizumab + cetuximab ± irinotecan improves survival in colorectal cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Cetuximab alone or in combination with i

Cetuximab alone or in combination with irinotecan effective against irinotecan-refractory colorectal cancer

✍ Les Lang 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Cetuximab Plus Irinotecan in Pretreated

Cetuximab Plus Irinotecan in Pretreated Metastatic Colorectal Cancer Progressing on Irinotecan: The LABEL Study

✍ Antonio C. Buzaid; Clarissa de Cerqueira Mathias; Florencia Perazzo; Sergio D. S 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 141 KB

MDR1polymorphism role in patients treate

MDR1polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer

✍ Bernard Paule; Vincent Castagne; Véronique Picard; Raphaël Saffroy; René Adam; C 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 210 KB

Effect of simvastatin plus cetuximab/iri

Effect of simvastatin plus cetuximab/irinotecan forKRASmutant colorectal cancer and predictive value of theRASsignature for treatment response to cetuximab

✍ Lee, Jeeyun; Hong, Yong Sang; Hong, Jung Yong; Han, Se Won; Kim, Tae Won; Kang, 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 796 KB